AKT1 and type 2 diabetes mellitus: Moreover, oral administration of BAIBA for 4 weeks in type 2 diabetic mice resulted in improved insulin signaling, by restoring Akt-IRS-1 (Tyr632 and Ser307) phosphorylation [30].